Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

1. WO2007150054 - COMPOSITIONS IMMUNOGÈNES CARACTERISÉES PAR UNE GLYCOSYLATION MODIFIÉE

Numéro de publication WO/2007/150054
Date de publication 27.12.2007
N° de la demande internationale PCT/US2007/071948
Date du dépôt international 22.06.2007
CIB
A61K 39/00 2006.01
ANÉCESSITÉS COURANTES DE LA VIE
61SCIENCES MÉDICALE OU VÉTÉRINAIRE; HYGIÈNE
KPRÉPARATIONS À USAGE MÉDICAL, DENTAIRE OU POUR LA TOILETTE
39Préparations médicinales contenant des antigènes ou des anticorps
CPC
A61K 39/0011
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
0005Vertebrate antigens
0011Cancer antigens
A61K 39/015
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
002Protozoa antigens
015Hemosporidia antigens, e.g. Plasmodium antigens
A61K 39/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
02Bacterial antigens
04Mycobacterium, e.g. Mycobacterium tuberculosis
G01N 33/6842
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
6803General methods of protein analysis not limited to specific proteins or families of proteins
6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
Y02A 50/386
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
50in human health protection
30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
38Medical treatment of vector-borne diseases characterised by the agent
381the vector-borne disease being caused by a virus
384of the genus Flavivirus
385the disease being Dengue
386the medicinal preparation containing antigens or antibodies, e.g. vaccines, antisera
Y02A 50/412
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
50in human health protection
30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
38Medical treatment of vector-borne diseases characterised by the agent
408the vector-borne disease being caused by a protozoa
411of the genus Plasmodium, i.e. Malaria
412the medicinal preparation containing antigens or antibodies, e.g. vaccines, antisera
Déposants
  • SHAH, Mrugesh [US/US]; US
Inventeurs
  • SHAH, Mrugesh; US
Mandataires
  • WHITE, Allen E. ; Fulbright & Jaworski L.L.P. Fulbright Tower 1301 Mckinney, Suite 5100 Houston, TX 77010-3095, US
Données relatives à la priorité
60/816,17624.06.2006US
Langue de publication anglais (EN)
Langue de dépôt anglais (EN)
États désignés
Titre
(EN) IMMUNOGENIC COMPOSITIONS HAVING ALTERED GLYCOSYLATIONS
(FR) COMPOSITIONS IMMUNOGÈNES CARACTERISÉES PAR UNE GLYCOSYLATION MODIFIÉE
Abrégé
(EN)
The disclosure relates methods for producing and identifying immunogenic compositions suitable for use as vaccine components. The immunogenic compositions are partially or completely deglycosylated pathogen related materials such as attenuated pathogens or pathogen outer surface components.
(FR)
La présente invention concerne des procédés de production et d'identification de compositions immunogènes utilisables en tant que composants vaccinaux. Lesdites compositions immunogènes sont constituées de matériaux associés à des agents pathogènes partiellement ou complètement déglycosylés, tels que des agents pathogènes atténués ou des composants de la surface externe d'agents pathogènes.
Dernières données bibliographiques dont dispose le Bureau international